Methods of treating chronic inflammatory diseases using a GM-CSF antagonist

Details for Australian Patent Application No. 2007323541 (hide)

Owner KaloBios Pharmaceuticals, Inc.

Inventors Yarranton, Geoffrey T.; Bebbington, Christopher R.

Agent Pizzeys

Pub. Number AU-B-2007323541

PCT Pub. Number WO2008/064321

Priority 60/860,780 21.11.06 US; 60/902,742 21.02.07 US

Filing date 21 November 2007

Wipo publication date 29 May 2008

Acceptance publication date 19 January 2012

International Classifications

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/505 (2006.01) - Pyrimidines

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

2 July 2009 PCT application entered the National Phase

  PCT publication WO2008/064321 Priority application(s): WO2008/064321

19 January 2012 Application Accepted

  Published as AU-B-2007323541

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007323545-Reducing withdrawal force in a safety IV catheter

2007323540-Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity